O. D. Abaan

Latest

• High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias
• NCI-60 whole exome sequencing and pharmacological CellMiner analyses
• The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology
• CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute